Hem › Non-Hodgkins lymfom › Colorado › Denver
Kliniska studier för Non-Hodgkins lymfom i Denver, CO
14 studier för Non-Hodgkins lymfom söker deltagare vid platser i och runt Denver (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
RekryterarFas 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
RekryterarFas 1/2
- Colorado Blood Cancer Institute ( Site 7000), Denver
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
RekryterarFas 1
- Colorado Blood Cancer Institute, Denver
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
RekryterarFas 1
- Colorado Blood Cancer Institute, Denver
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
RekryterarFas 1
- Colorado Blood Cancer Institute (Sarah Cannon), Denver
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RekryterarFas 1/2
- Colorado Blood Cancer Institute, Denver
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
RekryterarFas 1/2
- Colorado Blood Cancer Institute, Denver
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
RekryterarFas 3
- Colorado Blood Cancer Institute, Denver
DALY II USA/ MB-CART2019.1 for DLBCL
RekryterarFas 2
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
SynKIR-310 for Relapsed/Refractory B-NHL
RekryterarFas 1
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RekryterarObservationsstudie
- Kaiser Permanente-Franklin, Denver
- Colorado Blood Cancer Institute, Denver
- Rocky Mountain Cancer Centers-Midtown, Denver
- och 1 fler
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekryterarObservationsstudie
- Massive Bio SYNERGY-AI site, Denver
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
RekryterarFas 1
- Colorado Blood Cancer Institute, Denver
Non-Hodgkins lymfom-studier i andra städer
- New York City, NY31 studier
- Houston, TX31 studier
- Boston, MA26 studier
- Nashville, TN21 studier
- Philadelphia, PA20 studier
- Baldwin Park, CA19 studier
- Washington, DC18 studier
- Chicago, IL18 studier
- Atlanta, GA18 studier
- Milwaukee, WI18 studier
- Columbus, OH18 studier
- Dallas, TX17 studier
Andra studier i Denver
- Metastaserande cancer29 studier
- Bröstcancer29 studier
- Icke-småcellig lungcancer27 studier
- Multipelt myelom27 studier
- Kolorektal cancer23 studier
- Melanom19 studier
- Prostatacancer19 studier
- Cancer (alla typer)18 studier
- Äggstockscancer16 studier
- Lungcancer16 studier
- Endometriecancer15 studier
- Bukspottkörtelcancer13 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.